Myxoid Liposarcoma
📧 Sign up to get email alerts when something new happens for Myxoid Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 [Phase 1]
Phase 1/1b clinical trial evaluating NK cells engineered to express an affinity-enhanced T-cell receptor targeting NY-ESO-1 in patients with…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the safety and antitumor activity of Lete-Cel (GSK3377794) in HLA-A2+ patients with NY-ESO-1 positive syno…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. [Phase 2]
A Phase 2 trial evaluating the combination of trabectedin and pioglitazone in myxoid liposarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy [EARLY_Phase 1]
A Phase 1 trial update on N-803 for patients with progressive synovial sarcoma and myxoid/round cell liposarcoma who previously received ado…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer [Phase 1]
Phase 1 trial update of PeptiCRAd-1 reports safety signals and anti-tumor activity across multiple cancers; trial status is ACTIVE_NOT_RECRU…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma [Phase 2]
Spearhead 1, a Phase 2 trial in advanced synovial sarcoma or myxoid/round cell liposarcoma, has posted results; the study is currently activ…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas [Phase 1]
Itacitinib was studied in a Phase 1 trial for patients with refractory metastatic/advanced sarcomas, but the study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma [Phase 2]
Phase 2 study evaluating safety and antitumor activity of Lete-Cel (GSK3377794) in HLA-A2+ patients with NY-ESO-1 positive, previously untre…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) [Phase 1, Phase 2]
A rollover protocol update is described to allow continued access to the LSD1 inhibitor seclidemstat (SP-2577) in ongoing Phase 1/Phase 2 tr…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma [Phase 2]
Phase 2 trial of Letetresgene Autoleucel (engineered T cells) in NY-ESO-1 positive advanced myxoid/round cell liposarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma [Phase 2]
Phase 2 trial evaluating sirolimus with cyclophosphamide in metastatic or unresectable myxoid liposarcoma and chondrosarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma [EARLY_Phase 1]
Early Phase 1 trial of recombinant interferon gamma in soft tissue sarcoma (myxoid liposarcoma, round cell liposarcoma, synovial sarcoma) ha…
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 study of efatutazone dihydrochloride in patients with previously treated myxoid liposarcoma that cannot be removed surgically has co…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) [Phase 2]
Phase 2 trial update evaluating hypofractionated radiotherapy for myxoid liposarcoma of extremities or trunk wall.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma [Phase 2]
Phase 2 study evaluating trabectedin for localized myxoid liposarcoma reports safety and efficacy findings; results were posted in 2014.